Please upgrade your browser.
Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Sunitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Bevacizumab and sunitinib may also stop the growth of tumor cells by blocking blood flow to the tumor. Giving bevacizumab together with sunitinib may kill more tumor cells.
This randomized phase II trial is studying vaccine therapy and fludarabine to see how well they work compared to vaccine therapy alone in treating patients with stage IV kidney cancer.
The aim of this study is to evaluate the efficacy of AS1411 in patients with Metastatic Renal Cell Carcinoma.
At the Kidney Cancer Association, patient centered care begins with the first contact. Learn more in this two-minute-long video.
The Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) announced today the 20 bright oncology trainees who will be recognized with Merit Awards at the 2012 Genitourinary Cancers Symposium taking place February 2-4, 2012, in San Francisco.
Nicholas Vogelzang, MD, discusses the research highlights from the 2012 Genitourinary Cancers Symposium in San Francisco, California.
Hollywood celebrity Denise Richards, starring in Spike TV's hit series, "Blue Mountain State," invites fans to upload a photo to win a luncheon date. This contest aims to create greater awareness of kidney cancer and the need for a cure. In a companion contest fans can upload a video instead.
Sonographic technology was first developed in WWII to locate objects under water.
Cancer advocate Michael Lawing of Forest City, North Carolina recently participated in the evaluation of research applications submitted to the Peer Reviewed Cancer Research Program (PRCRP) sponsored by the Department of Defense.
2012. A milestone in my professional career marking the 30th anniversary since I finished my medical oncology fellowship and started practicing in the field.
|NeonCRM by Neon One|